Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled Trial
Thomas Chatzikonstantinou(G. Papanikolaou General Hospital), Dimitrios Kyrou(Centre for Research and Technology Hellas), Stephan Kiefer(Fraunhofer Institute for Biomedical Engineering), Christos Demosthenous(G. Papanikolaou General Hospital), Richard Rosenquist(Karolinska University Hospital), Karin E. Smedby(Karolinska University Hospital), Jonathan Reston, Lefteris Koumakis, Tina Garani-Papadatos(University of West Attica), Norbert Graf(Saarland University), Christina Karamanidou(Centre for Research and Technology Hellas), Anastasia Chatzidimitriou(Karolinska Institutet), Pantelis Natsiavas(Centre for Research and Technology Hellas), George Zacharioudakis(Foundation for Research and Technology Hellas), Julie Ling(World Health Organization Regional Office for Europe), Panagiotis Argyropaidas(Foundation for Research and Technology Hellas), Michael Doubek(Central European Institute of Technology), Κώστας Σταματόπουλος(Centre for Research and Technology Hellas), Annette Sander(Athens Medical Center), Christine Kakalou(Centre for Research and Technology Hellas), Charalampos Pontikoglou(University of Crete), Marcel Meyerheim(Saarland University), Jana Didi(Central European Institute of Technology), Harriet Ryblom(Karolinska University Hospital), Eleni Kazantzaki(University of Crete), Panos Bonotis(Centre for Research and Technology Hellas), Helen Α. Papadaki(University of Crete), Niki Stavroyianni(G. Papanikolaou General Hospital), Maria Chatzimina(Mediterranean University), Sheila Payne(Lancaster University), Paolo Ghia(Vita-Salute San Raffaele University), Fatima Schera(Fraunhofer Institute for Biomedical Engineering), Sotiria Besikli‐Dimou(Centre for Research and Technology Hellas), Cathy Payne(European Association for Palliative Care), Christina Papangelou(Centre for Research and Technology Hellas), Maria Vasilopoulou(Centre for Research and Technology Hellas), Georgios Karakatsoulis(University of Ioannina), Stefan Hoffman(Software (Germany))
Cited by 0
Related Papers
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|890
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
|Arthritis & Rheumatism|2006|888